BiotechTube
Home/Inthera Bioscience/Bernd Hentsch, PhD
BH

Bernd Hentsch, PhD

Chief Development Officer

Inthera Bioscience

Therapeutic Areas

Oncology

Inthera Bioscience Pipeline

DrugIndicationPhase
INTH-454Advanced Prostate Cancer (CRPC) and Colorectal Cancer (CRC)IND-ready / Pre-clinical

Leadership Team at Inthera Bioscience

MK
Mark Krul
Chief Executive Officer
KA
Kim Andersen, PhD
Head of Drug Discovery
FH
Frank Hennecke, PhD
Head of CMC Development
CA
Catherine Ammann
Head HR & Administration
View full Inthera Bioscience profile